LB-456640-2 MULTICENTER FIRST IN HUMAN CLINICAL FEASIBILITY STUDY TO EVALUATE SAFETY AND EFFICACY OF LOW ENERGY MULTI-PULSE THERAPY FOR VENTRICULAR TACHYCARDIA

Implantable cardioverter defibrillators (ICD) are effective in terminating ventricular tachycardia (VT). High energy shocks are deleterious and anti-tachycardia pacing is limited in suppressing VT. Multi-Pulse Therapy (MPT) is a novel anti-arrhythmic therapy which has a unique waveform sequence including multiple stages of electrical pulses, requires less energy compared to conventional biphasic defibrillation.